Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report

MLA

Akira Taniguchi, et al. “Continuous Infusions of B Domain-Truncated Recombinant Factor VIII, Turoctocog Alfa, for Orthopedic Surgery in Severe Hemophilia A: First Case Report.” International Journal of Hematology, vol. 108, Jan. 2018, pp. 199–202. EBSCOhost, https://doi.org/10.1007/s12185-018-2415-5.

APA

Akira Taniguchi, Yasuhito Tanaka, Ryohei Kobayashi, Midori Shima, Masahiro Takeyama, Yasuaki Nakanishi, Keiji Nogami, Kenichi Ogiwara, & Yusuke Inagaki. (2018). Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report. International Journal of Hematology, 108, 199–202. https://doi.org/10.1007/s12185-018-2415-5

Chicago

Akira Taniguchi, Yasuhito Tanaka, Ryohei Kobayashi, Midori Shima, Masahiro Takeyama, Yasuaki Nakanishi, Keiji Nogami, Kenichi Ogiwara, and Yusuke Inagaki. 2018. “Continuous Infusions of B Domain-Truncated Recombinant Factor VIII, Turoctocog Alfa, for Orthopedic Surgery in Severe Hemophilia A: First Case Report.” International Journal of Hematology 108 (January): 199–202. doi:10.1007/s12185-018-2415-5.